Jones v. Wells Fargo (Los Angeles, California).
South Carolina v. Janssen Pharmaceutica, scheduled to begin February 14 in Spartanburg, South Carolina, will be the third jury trial involving claims that Johnson & Johnson overcharged for its antipsychotic drug Risperdal (generically known as "Risperdone"). South Carolina's alleged Medicaid overcharge damages are said to run into the billions.
Pennslyvania asserted a simlar claim, but the case was dismissed in June, 2010, after the state had presented its evidence to a jury. But in Louisiana a jury awarded $257M against Johnson & Johnson last October, and in 2009 a West Virginia judge awarded $4.4M in damages. Several other states' Risperdal claims are still pending, including Arkansas, Montana, New Mexico, Texas, and Utah.
0 Comments Click here to read/write comments
Topics: Pharmaceutical, Commercial Law, SC v. Janssen Pharmaceutica
The jury in Florida Gas Transmission v. Florida Department of Transportation today awarded over $82M in damages against the Florida DOT for breaching an agreement to reimburse for the costs of relocating a gas pipeline.
0 Comments Click here to read/write comments
Topics: Real Estate, Florida Gas v. Florida DOT, Energy Law, Commercial Law
Former Siga CFO Tom Konatich testified today that Siga originally contacted PharmAthene and offered to license Siga's smallpox drug, ST-246, because Siga needed to improve its cash flow quickly. But in response, according to Mr. Konatich, PharmAthene told him that they were not interested in a license arrangement, and that "it was a merger or nothing."
0 Comments Click here to read/write comments
Topics: Commercial Law, PharmAthene v. Siga
Florida Gas v. Florida DOT opening statements were heard today in Fort Lauderdale, Florida.
0 Comments Click here to read/write comments
Topics: Florida Gas v. Florida DOT, Energy Law, Commercial Law
